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Abstract
Cardiac depression in sepsis is associated with the increased morbidity and mortality. Although myofilaments damage,
autonomic dysfunction, and apoptosis play roles in sepsis-induced myocardial dysfunction, the underlying mechanism is
not clear. All of these possible factors are related to NFkB signaling, which plays the main role in sepsis signaling.
Thaliporphine was determined to possess anti-inflammatory and cardioprotective activity by suppressing NFkB signaling in
rodents. The purpose of this study is to further prove this protective effect in larger septic animals, and try to find the
underlying mechanisms. The systolic and diastolic functions were evaluated in vivo by pressure-volume analysis at different
preloads. Both preload-dependent and -independent hemodynamic parameters were performed. Inflammatory factors of
whole blood and serum samples were analyzed. Several sepsis-related signaling pathways were also determined at protein
level. Changes detected by conductance catheter showed Thaliporphine could recover impaired left ventricular systolic
function after 4 hours LPS injection. It could also reverse the LPS induced steeper EDPVR and gentler ESPVR, thus improve
Ees, Ea, and PRSW. Thaliporphine may exert this protective effect by decreasing TNFa and caspase3 dependent cell
apoptosis, which was consistent with the decreased serum cTnI and LDH concentration. Thaliporphine could protect sepsis-
associated myocardial dysfunction in both preload-dependent and -independent ways. It may exert these protective effects
by both increase of ‘‘good’’-PI3K/Akt/mTOR and decrease of ‘‘bad’’-p38/NFkB pathways, which followed by diminishing
TNFa and caspase3 dependent cell apoptosis.
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Introduction
Septic shock is an increasingly severe clinical syndrome and the
primary cause of death in intensive care units characterized by
hemodynamic dysfunction of several organs [1,2]. This is due to
moreandmoreusesofdiagnosticortherapeuticinvasiveprocedures
and the application of immunosuppressive chemotherapy. It
develops from initial normal host response to the infection which
is amplified and dysregulated. The features of sepsis include fever,
diminished urine output, thrombocytopenia, hypotension, and
multiple organ failure including myocardial dysfunction [3]. Severe
septic shock presents with impaired systolic function, abnormal
diastolic function of heart, marked peripheral vasodilatation, and
decrease in central blood volume [4,5]. The pathogenesis of the
myocardial dysfunction in sepsis is multifactorial, both intrinsic
myocardial depression [6] and factors secondary to the acidosis,
hypotension, hypoxia and circulating inflammatory factors (IL-1b,
TNFa, platelet-activating factor, lysozyme, nitric oxide, and free
radicals) may play important roles [7,8,9]. Lipopolysaccharide
(LPS),amajorcomponentoftheoutermembraneofGramnegative
bacteria,activatesseveralintracellular signalingpathwaysincluding
mainly NFkB and MAP kinase signaling, leading cells to a pro-
inflammatory state with the secretion of cytokines and over-
expression of several markers of the immune response [10]. The
release of different cytokines may be responsible for both intrinsic
and extrinsic apoptosis pathways. Recently, some evidences suggest
thatLPSalsoinvolvedinthePI3Kpathwayfollowedbymammalian
target of rapamycin (mTOR) signaling[11], which could negatively
regulate p38 dependent matrix metalloproteinase-9 (MMP9)
activation.
Thaliporphine, a phenolic aporphine alkaloid isolated from
plants of several families such as Lauracea [12], possesses protective
effects on multiple organs of LPS-induced endotoxemic rodents in
our previous study [13]. It could suppress NO, superoxide anion,
and TNFa production, and decrease infiltration of inflammatory
cells into injured tissues. In our recent study, we also found
Thaliporphine could ameliorate cardiac depression through
attenuating toll-like receptor 4 (TLR4) signaling and decreasing
downstream NFkB activation. This effect of Thaliporphine further
prevented cardiac sarcoplasmic reticulum Ca
2+-ATPase
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39174(SERCA2) function from nitrosylation by peroxynitrite via de-
creasing iNOS and TNFa expression of endotoxemic rats [14].
However, the detailed underlying mechanism of Thaliporphine on
endotoxemic hearts remains to be further examined, especially in
larger animals such as rabbits and dogs. For the present study, we
used LPS-induced endotoxemic rabbits, an animal model recog-
nized to mimic abnormal cardiac function of human sepsis, to
investigate the acute protective effects of Thaliporphine and the
underlying mechanisms.
Materials and Methods
1. Thaliporphine Synthesis
Thaliporphine was synthesized from glaucine and purified by
column chromatography, followed by identification with spectro-
metric methods (mass, NMR). Its purity (.99%) was established
by HPLC with retention time of 15.17 min under the following
conditions: Lichrospher RP-18e, 5 mm, 4.06125 mm; eluent
MeOH-0.01 M KH2PO4/H2O (pH 7.02) 60:40; flow rate
1.0 ml/min; injection volume 20 ml (1 mg/ml); detection 218 nm.
2. Animals
This study was approved by National Taiwan University
IACUC and performed in accordance with the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85-23, revised 1996). Male New
Zealand White rabbits weighing 1.2 to 1.5 kg were housed in
individual cages in a controlled environment with free access to
food and water. The rabbits were randomly divided into 5 groups:
Sham, LPS 1 mg/kg (LPS), LPS pretreated with 1 mg/kg
Thaliporphine (LPS/T1), LPS pretreated with 3 mg/kg Thali-
porphine (LPS/T3), 3 mg/kg Thaliporphine alone (T3). There
are six animals in each group. Endotoxemia was induced by
intravenous injection of lipopolysaccharides from Escherichia coli,
Salmonella enteritidis, and Salmonella minnesota (Sigma Chemical, St.
Louis, MO) 1 mg/kg through marginal ear vein of rabbits which
were fasted from the night before the experiment began. The
cardiac function and blood analysis were monitored 4 hours after
LPS injection with or without 30 min pretreatment of 1 or 3 mg/
kg Thaliporphine.
3. Analysis of Hemodynamic Characteristics in vivo
All groups of animals were anesthetized with 3% isoflurane
under mechanical ventilation. After tracheostomy, a micro tip
pressure-volume catheter (3.0F; Scisense Instrument, ON, Ca-
nada) was inserted into the right carotid artery to measure blood
pressure and flow under stable condition for 5 min, and then
advanced into the left ventricle under pressure monitor. Signals of
pressure and volume associated with lead II EKG were
continuously recorded at the sampling rate of 1000 Hz using
PONEMAH real-time acquisition interface P3P Plus coupled to
a digital converter (ACQ-16). All pressure-volume loop data were
analyzed by using a program of PONEMAH Life Sciences Suite
from Data Sciences International (DSI Corporate Headquarters,
St. Paul, MN). The hemodynamic parameters included heart rate
(HR), mean arterial pressure (MAP), left ventricular end-systolic
pressure (LVSP), maximal velocity of pressure rise (+dP/dt), and
maximal velocity of pressure fall (2dP/dt). The contractility
parameters were determined under conditions of intermittent
changing preload, elicited by transiently inflating a balloon
previously inserted into abdominal inferior vena cava through
femoral vein. These data allowed computer calculation of preload-
independent variables such as time-varying end-systolic elastance
(Ees), arterial elastance (Ea), and preload-recruitable stroke work
(PRSW).
4. Measurement of Blood and Serum Parameters
Blood samples were collected from carotid artery at the end of
experiments and then centrifuged at 10000 rpm for 5 min to
obtain serum. Blood pH and cardiac troponin I was measured by
iSTAT Portable Clinical Analyzer with G3+ and cTnI cartridge
(Abbott Point of Care Inc. Princeton, NJ, USA). Blood glucose was
measured by strips of OneTouch blood glucose meter (LifeScan
Ltd., Canada). Serum LDH (CytoTox 96, Non-Radioactive
Cytotoxicity Assay, Promega Corporation, WI, USA) was
measured according to the manufacturer’s instructions. WBC
count was measured on a hematology analyzer in whole blood
mode (KX-21N, Sysmex, MA, USA). The number of PMNs was
calculated by multiplying the percent PMN in the sample by the
total WBC count.
5. Total Protein Extraction of Myocardial Tissues and
Western Blotting
Ventricles from all groups of rabbits were homogenized by using
a Dounce homogenizer in RIPA lysis buffer (137 mM NaCl,
5 mM EGTA, 5 mM EDTA, 25 mM Tris, 0.5% sodium deox-
ycholate, 0.1% SDS, and 0.1% Triton X-100, adjusted to pH7.5),
containing protease inhibitor cocktail for mammalian cell and
tissue extracts (Sigma-Aldrich Co., USA). The lysates were
disrupted in advance by sonication at 4uC for 30 min, and
centrifuged at 14000 rpm for 10 min at 4uC to collect the
supernatant as total protein extract. Protein concentrations were
determined by using Bradford Protein Assay kit (Bio-rad
Laboratories Inc, CA, USA).
Samples of equal protein content (100 mg each lane) were
subjected to SDS-PAGE and electrotransferred to PVDF mem-
branes (Immobilon-P membranes, Millipore Corp., Bedford, MA,
USA). The primary antibodies employed included MMP9,
mTOR, p38, phospho-p38 (Thr 180/Tyr 182), PI3K, Akt,
phospho-Akt (Ser 473), a-tubulin, Bcl2, phospho-NFkB p65 (Ser
536), TNFa (Santa Cruz Biotechnology, Inc. Santa Cruz, CA,
USA), and b-actin (Sigma-Aldrich Co., USA). The detection of
specific proteins in immunoreactive bands was carried out by
enhanced chemiluminescence (ECL kit, PerkinElmer Life
Sciences, Inc, Boston, MA) and quantified by GelDoc-It imaging
system (UVP, CA, USA).
6. Nuclear Protein Extraction and Electrophoretic Mobility
Shift Assay (EMSA)
Nuclear protein extracts were obtained by using Nuclear
Extraction Kit (Panomics Inc., Dumbarton Circle Fremont, CA)
according to the manufacturer’s instruction with its supplemented
protease and phosphatase inhibitors. LightShiftH Chemilumines-
cent EMSA Kit was used to identify the interaction of NFkB with
DNA. Nuclear proteins (10 mg) were incubated with the biotin-
labeled probe (AGTTGAGGGGACTTTCCCAGGC) and sub-
jected to 6% nondenaturing polyacrylamide gel electrophoresis.
After transferring to nylon membrane, the oligos on the
membrane were fixed using UV cross-linker. The blot was then
blocked and incubated in streptavidin–HRP containing mixture.
7. TUNEL Staining for Apoptosis
Hearts from all groups of rabbits were removed and immersed
in 4% paraformaldehyde for overnight. The hearts were then
embedded in molten paraffin, and serial 5 mm myocardial sections
were cut. The sections were placed on poly-L-lysine-coated slides
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dewaxed by immersion in xylene for 10 min and were sequentially
rehydrated by graded ethanol. The antigen was retrieved with
proteinase K method. Terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) staining was performed using
a commercial kit (In Situ Cell Death Detection Kit, Fluorescein,
Roche Diagnostics.) with modification of the recommended
protocol. The fluorescein-12dUTPlabeled DNA was directly
visualized and analyzed by fluorescence microscopy (Olympus
IX70 research inverted system microscope).
8. Caspase 3 Activity of Myocardial Tissues
Caspase 3 Colorimetric Activity Assay Kit, DEVD (Chemicon
International, Inc, USA) was used to measure caspase 3 activity by
microplate ELISA reader (VICTOR X, PerkinElmer, Waltham,
MA, USA) according to the manufacturer’s instructions.
9. Cytokine Protein Array
To determine levels of select cytokines and chemokines,
cytokine array membranes (R&D Systems, Minneapolis, MN)
were treated with serum from each group. Membranes were then
developed with enhanced chemiluminescence (ECL) reagents
(Millipore, Billerica, MA), and images were acquired and analyzed
with the G-box imaging system (Syngene, India).
10. Statistical Analysis
The results were presented as means 6 standard error of the
mean (S. E.M.). Significant differences between groups were
determined by one-way ANOVA with post hoc analysis using the
Bonferroni t-test.
Table 1. Effects of thaliporphine on basic and blood parameters of endotoxemic rabbits.
Group Sham LPS LPS/T1 LPS/T3 T3
Body Weight (kg) 1.3860.04 1.3760.05 1.3460.05 1.3360.06 1.2860.03
Blood pH 7.5160.02 7.4560.01* 7.4660.04 7.5560.02
## 7.5060.01
Blood Glucose (mg/dL) 157.00612.73 68.17613.54** 114.67613.29
# 143.1762.95
## 149.7568.01
cTnI (ng/mL) 1.0860.45 8.7061.76** 6.4461.74 3.9860.86
# 1.4060.12
LDH (O.D.) 1.3160.06 2.2060.18** 2.2260.21 1.7560.12
# 1.4060.10
WBC (10
9/L) 6.661.57 3.8660.45* 5.0261.20 4.3661.06 5.9060.25
PMN (%) 24.1261.71 32.7864.23** 23.1864.43 26.9360.85 23.2861.86
PMN Count (10
9/L) 1.5960.10 1.2860.01* 1.1060.23 1.3660.22 1.3760.09
Values are means6S.E. cTnI, cardiac troponin I; LDH, lactate dehydrogenase; WBC, white blood cell; PMN, polymorphonuclear neutrophil. * P,0.05 and ** P,0.02 as
compared with sham group;
# P,0.05 and
## P,0.02 as compared with LPS group.
doi:10.1371/journal.pone.0039174.t001
Figure 1. Thaliporphine could significantly ameliorate depressed hemodynamic characteristics of endotoxemic rabbits. A. Pressure
(top) and dP/dt (bottom) signals obtained with the pressure-volume conductance catheter system from sham, LPS (1 mg/kg), LPS plus 3 mg/kg
Thaliporphine (LPS/T3), and 3 mg/kg Thaliporphine alone (T3) treated rabbits. B. Representative P-V loops at different preloads, showing differences
in both end-systolic P-V relation (ESPVR) and end-diastolic P-V relation (EDPVR) between three groups. The less steep ESPVR and increased EDPVR in
LPS treated animals indicate decreased contractile function and increased diastolic stiffness. Co-administration of 3 mg/kg Thaliporphine could
reverse both cardiac depressive conditions.
doi:10.1371/journal.pone.0039174.g001
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Group Sham LPS LPS/T1 LPS/T3 T3
HR (bpm) 285.50614.37 312.67615.03 302.83613.60 310.5065.86 290.25617.21
MAP (mmHg) 78.6161.68 64.4864.69* 60.6762.20* 69.9364.95* 80.9461.56*
LVSP (mmHg) 96.6064.92 75.0864.04** 75.3262.17** 89.9562.44
## 103.767.20
+dP/dt (mmHg/s) 5276.806777.21 2988.086251.31** 2762.486312.45** 4075.106374.31
# 5720.186721.28
2dP/dt (mmHg/s) 6413.756629.40 3442.976514.73** 3525.886554.76** 4720.706400.39
# 6428.756734.02
Ees (mmHg/mL) 85.667.8 49.964.8** 57.868.5** 69.565.3
# 81.163.1
Ea (mmHg/mL) 277.0629.7 165.5630.2** 227.7624.3 238.1621.6
## 281.6610.3
PRSW (mmHg) 26.9767.75 14.1362.56** 20.9064.22 27.2363.81
## 29.1266.64
Values are means6S.E. HR, heart rate; MAP, mean arterial pressure; LVSP, left ventricular systolic pressure; +dP/dt, maximal velocity of pressure rise; 2dP/dt, maximal
velocity of pressure fall; Ees, end systolic elastance; Ea, arterial elastance; PRSW, slope of preload recruitable stroke work. * P,0.05 and ** P,0.02 as compared with
sham group;
# P,0.05 and
## P,0.02 as compared with LPS group.
doi:10.1371/journal.pone.0039174.t002
Figure 2. Comparison of the protein expression of phospho-p38, total p38, phospho-p65, MMP9, and TNFa between sham, LPS,
and LPS plus 3 mg/kg Thaliporphine (LPS/T3) groups. Representative Western blots are shown at top A. and densitometric analyses at
bottom B. The data of phospho-p65, MMP9, and TNFa were normalized with b–actin and phospho-p38 was normalized with total P38. Plots
represent means+S.E. * P,0.05 as compared with sham group;
# P,0.05 as compared with LPS group.
doi:10.1371/journal.pone.0039174.g002
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1. Effect of Thaliporphine on Basic and Serum Parameters
of Endotoxemic Rabbits
Table 1 summarized and compared some basic and serum
parameters between different groups of rabbits. There was no
significantdifferenceofmeanbodyweightbetweenfourgroups,but
blood pH and glucose level were both lower after 4 hours LPS
injection than were sham (7.4560.01, 68.17613.54 mg/dl vs.
7.5160.02,157.00612.73 mg/dl,respectively). Co-administration
ofThaliporphineat1and3 mg/kgcoulddose-dependentlyrecover
both blood pH and glucose (7.4660.04, 114.67613.29 mg/dl and
7.5560.02, 143.1762.95 mg/dl, respectively).
Serum cardiac troponin I (cTnI) and Lactate dehydrogenase
(LDH) were also examined. LPS injection increased both cTnI and
LDH release (8.7061.76 ng/ml and 2.260.18 compared to sham
group 1.0860.45 ng/ml and 1.3160.06). Co-administration of
Thaliporphine could dose-dependently reduce the cTnI value
(6.4461.74 and 3.9860.86 ng/ml at dose 1 and 3 mg/kg, re-
spectively), but only 3 mg/kg could significantly decrease the LDH
level.
2. Effect of Thaliporphine on Hemodynamic
Characteristics of Endotoxemic Rabbits
Pressure-volume (P-V) analysis is a useful approach for
examining intact chamber function independently of loading
conditions. This analysis has been widely used in large animal
studies and humans. The systolic and diastolic functions were
evaluated in vivo at different preloads. After LPS injection (1 mg/
kg, i.v.) for 4 hours, the basic hemodynamic properties of rabbits
were depressed as shown in Figure 1A and summarized in Table 2.
There was no significant change in heart rate among four groups.
The mean arterial pressures was 78.6161.68 mmHg in control
group, and became 64.4864.69 mmHg (P,0.02 vs. control) in
LPS-group. Co-administration with 1 and 3 mg/kg Thaliporphine
could not significantly elevate the MAP of LPS-induced endo-
toxemic rabbits to control value (60.6762.20 and
69.9364.95 mmHg, respectively). Changes detected by conduc-
tance catheter readings showed that left ventricular systolic
function was impaired after 4 hours in LPS-injected rabbits
compared to sham animals. With LPS injection, left ventricular
systolic pressure was significantly suppressed to
75.0864.04 mmHg compared to 96.6064.92 mmHg of control
group. Both +dP/dt and 2dP/dt were also significantly lower
than in sham-treated animals (2988.086251.31 vs.
5276.806777.21 mmHg/s, and 3442.976514.73 vs.
6413.756629.40 mmHg/s). Thaliporphine could improve the
LVP as the dose increased (75.3262.17 and 89.9562.44 mmHg
in 1 and 3 mg/kg Thaliporphine groups, respectively), but only
high dose (3 mg/kg) Thaliporphine could significantly recover the
LPS effects on both +dP/dt and 2dP/dt (4075.106374.31 and
4720.706400.39 mmHg/s, respectively).
Figure 3. Comparison of the NFkB translocation between sham, LPS, LPS plus 3 mg/kg Thaliporphine (LPS/T3), and Thaliporphine
alone (T3) groups. A. Nuclear and cytosolic fractions were separately harvested for Western blot analysis of NFkB p65. B. The ratio of nuclear
fraction of NFkB to cytosolic fraction was quantified. Plots represent means+S.E. * P,0.05 as compared with sham group;
# P,0.05 as compared with
LPS group. C. The translocation of NFkB p65 was performed with nuclear fractions in different groups by Electrophoretic mobility shift assay (EMSA).
The arrows indicate the NFkB specific band and free probe. pc, positive control; ec, EMSA control (without probe); cp, cold (unlabeled) probe against
the sample from LPS treated group.
doi:10.1371/journal.pone.0039174.g003
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cava occlusions in three groups of rabbits. ESPVR was steeper in
sham group, suggesting that decreased systolic performance in
LPS treated group. On the other hand, the slope of EDPVR was
increased in LPS animals, indicating increased end-diastolic
stiffness. Co-administration of 3 mg/kg Thaliporphine could
reverse both cardiac depressive conditions. In addition to these
above parameters, P-V loops at different preloads could be used to
derive some other systolic function indexes that were preload-
independent, such as Ees, Ea, and PRSW.
Ees is an index of contractility, which is the slope of end-systolic
pressure-volume relationship; Ea is a measure of arterial load and is
calculated as the simple ratio of ventricular end-systolic pressure to
strokevolume;PRSWisthelinearregressionofstrokeworkwithend
diastolic volume. The Ees, Ea, and PRSW, three preload-
independent parameters, were all markedly and significantly lower
in LPS than in sham groups (49.964.8 vs. 85.667.8 mmHg/ml,
165.5630.2 vs. 277.0629.7 mmHg/ml, 14.1362.56 vs.
26.9767.75 mmHg, respectively). Thaliporphine could dose-de-
pendently preserve the Ees and Ea (57.868.5 and
227.7624.3 mmHg/ml at 1 mg/kg, 69.565.3 and
238.1621.6 mmHg/ml at 3 mg/kg), and recover the PRSW
(20.9064.22 mmHgat1 mg/kg, 27.2363.81 mmHgat 3 mg/kg).
3. Effect of Thaliporphine on p38 MAP Kinase/NFkB and
PI3K/Akt/mTOR Signaling in Myocardial Tissues
p38 MAP kinase/NFkB and PI3K/mTOR are two LPS-
induced signaling pathways in cardiomyocytes. In 4 hours LPS-
treated rabbit hearts, the protein expression levels of phospho-p38
MAP kinase, phospho-p65 NFkB, MMP9, and especially TNFa
were all increased as compared with sham (Figure 2). Thalipor-
phine at 3 mg/kg could diminish these increases significantly
without changes of total p38 expression. In LPS group, the
abundance of the NFkB p65 subunit was increased in the nuclear
fraction and slightly decreased in the cytosolic fraction of rabbit
heart tissue, suggesting that LPS induces the translocation of
NFkB into the nucleus (Fig. 3A). Thaliporphine at 3 mg/kg
significantly reduced the ratio of nuclear fraction of p65 to
cytosolic fraction (Fig. 3B). The binding between NFkB p65 and
DNA was also enhanced by LPS, and reversed by 3 mg/kg
Thaliporphine pretreatment (Fig. 3C). Figure 4 shows that 3 mg/
kg Thaliporphine could reverse the decrease of phopho-Akt and
mTOR expression by 4 hours LPS treatment. Phospho-Akt was
normalized with total Akt expression. However, the expression
level of PI3K was not altered with LPS plus Thaliporphine
treatment or LPS alone.
4. Effect of Thaliporphine on Apoptosis and Caspase3
Activity in Myocardial Tissues
Apoptosis is determined by TUNEL staining and confirmed
with caspase3 activity measurement. TUNEL staining enables the
highly sensitive detection of apoptosis in tissue and single cells, and
Caspase3 is activated in the apoptotic cell both by extrinsic (death
ligand) and intrinsic (mitochondrial) pathways. After four hours
treatment with 1 mg/kg LPS, the fraction of TUNEL (Fig. 5A)
positive nuclei was increased from 0.9060.20% to 4.9960.26%
(Fig. 5C), which was consistent with the increase of caspase3
activity (Figure 5D). Co-administration of 3 mg/kg Thaliporphine
reduced both caspase 3 activity and cell apoptosis.
5. Effect of Thaliporphine on Cytokine Release
Serum from LPS injected group showed a marked increase in
the expression of three cytokines, including cytokine-induced
neutrophil chemoattractant (CINC)-1, tissue inhibitor of metallo-
proteinase (TIMP)-1, and vascular endothelial growth factor
(VEGF). Pretreated with Thaliporphine at 3 mg/kg abolished
the expression of these proteins. No difference was observed
between the effects of Thaliporphine and sham group on cytokine
expression (Fig. 6).
Discussion
Myocardial dysfunction is an important manifestation in sepsis
[9,15]. Decrease in ventricular systolic function have been found
consistently in association with sepsis in humans [16], animals
[17], isolated hearts or papillary muscle of animal models [18].
Most experimental models, such as endotoxemic animals, reveal
hypovolemia, which is not the direct evidence for myocardial
depression. Both elevated sympatho-adrenal activation and de-
creased vascular resistance in endotoxemia may mask myocardial
depression [19]. Coronary circulation, myocardial metabolism,
and humoral mediators all play important roles in myocardial
dysfunction. Cardiac depression of human sepsis is not caused by
the hypotension and hypoperfusion of the shock state since septic
patients have high coronary flow and diminished coronary artery-
coronary sinus oxygen difference [20]. Discussions on the true
involvement of the heart in sepsis and septic shock, regardless of
hemodynamic conditions, date back to the early 1960s [21], when
Figure 4. Comparison of the protein expression of PI3K,
phospho-Akt, total Akt, and mTOR between sham, LPS, and
LPS plus 3 mg/kg Thaliporphine (LPS/T3) groups. Representative
Western blots are shown at top A. and densitometric analyses at
bottom B. The data of PI3K and mTOR were normalized with b–actin
and phospho-Akt was normalized with total Akt. Plots represent
means+S.E. * P,0.05 as compared with sham group;
# P,0.05 as
compared with LPS group.
doi:10.1371/journal.pone.0039174.g004
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Although the effects of sepsis on cardiac function have been the
subject of much investigation, the pathophysiology of this
condition remains incompletely understood [22]. There were
mechanisms involved in the pathophysiology of myocardial
dysfunction in sepsis include inflammatory, mitochondrial dys-
function, autonomic dysregulation, and cell death [23].
Left ventricular pressure has been widely used as the cardiac
contractile parameters, but it is recognized that they are all
preload dependent, which cannot reliably be used in models that
preload are altered [24]. Therefore, the pressure-volume (P-V)
relationship obtained by varying the cardiac loading is widely
used, which is relatively specific index for preload-independent
contractility [25]. In endotoxemic volunteers or animals, this
relationship is decreased, even without hypotension [26,27]. In
the present study, not only preload-dependent parameters LVSP,
+dP/dt, and -dP/dt, but also preload-independent indexes of
cardiac contractility, Ees (the slope of end-systolic pressure-
volume relationship) and PRSW (the linear regression of stroke
work with end diastolic volume) were measured and found all
these parameters were decreased in LPS group compared to
sham group. Our findings of impaired LV systolic function in
septic rabbit, especially preload-independent parameters after
LPS treatment, are consistent with previous observations by
others [28].
Although there are abundant studies regarding to the mechan-
isms of LPS induced cardiac depression, the main mechanisms
remain controversial [9,15,29]. LPS activates a broad range of
signaling pathways in cardiomyocytes, including MAP kinase and
NFkB cascade, which induced complicate inflammatory cascades,
cytokine release, and apoptosis [30]. Three types of MAP kinases
(ERK1/2, p38, and JNK) can be activated by LPS in
cardiomyocytes [31,32]. They played roles in the activation of
NFkB signaling, release of cytokines, and conversion of the
Figure 5. Thaliporphine significantly decreased cardiomyocytes apoptosis. A. Apoptosis evidenced by TUNEL staining of apoptotic nuclei
in different groups was compared. B. The morphology of cells was viewed under a light microscope. C. The fraction of apoptotic cells in heart tissue
of all groups was quantified by 10 random fields in each slice (four slices in each group). D. Caspase3 activity was examined and expressed by
means+S.E. * P,0.05 as compared with sham group;
# P,0.05 as compared with LPS group.
doi:10.1371/journal.pone.0039174.g005
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are in general agreement with previous studies implicating the role
of p38 MAP kinase on the production of cytokines (TNFa- and IL-
1b) from cardiomyocytes by LPS treatment [33,34]. NFkB
signaling is responsible for not only the generation of these
inflammatory factors but also their effects on inflammation and
apoptosis [35,36,37]. Septic serum can be viewed as a pool of
inflammatory factors, such as IL-1b- or TNFa, both from
myocytes themself or other cells have potential to activate many
signaling pathways of cardiomyocytes. In this study, we found LPS
could significantly induce CINC-1, TIMP-1, and VEGF release,
and Thaliporphine at 3 mg/kg significantly reverse the effects with
cytokine protein array. We also measured IL-1b, IL-6, and IL-10
level with ELISA kits for human sample. However, maybe because
of the species difference or sensitivity, we could not get any
meaningful data from all samples (data not shown). Accumulating
evidences indicate that myocardial TNFa (versus systemically) is
an autocrine contributor to myocardial dysfunction and apoptosis
in sepsis and chronic heart failure [38]. TNFa was reported to
cause cardiomyocytes apoptosis and followed by decrease of
myocyte contraction by about 25% [38,39].
Not only the main signaling pathway LPS induced, recent study
suggests LPS also stimulates PI3K/Akt/mTOR pathway and
demonstrates mTOR has a strong negative regulatory role in
controlling NFkB activation and MMP9 expression in different
cell models [11,40]. mTOR could decrease LPS-induced mitogen-
and stress-activated protein kinase-1 (MSK1) activation through
reducing phosphorylation of p38 MAP kinase, which acts
upstream of NFkB [41]. MMP9 plays a pivotal role in the
turnover of extracellular matrix and in the migration of immune
cells at injury sites [42], which was also induced by LPS associated
NFkB activation.
Thaliporphine, a novel aporphine alkaloid, was proved to
increase survival and ameliorate cardiac depression in small
endotoxemia animals [13,14]. In this study, we first demonstrated
3 mg/kg Thaliporphine could restore both preload-dependent
and independent hemodynamic cardiac depression parameters of
large endotoxemic animal, although 1 mg/kg Thaliporphine
could only reverse some of them. Our results indicate Thalipor-
phine protect rabbit heart from endotoxemic injury by decreasing
p38 MAP kinase, NFkB, MMP9, TNFa expression and increasing
PI3K/Akt/mTOR pathway. The decrease of ‘‘bad’’ and increase
of ‘‘good’’ pathways resulted in following protection effects against
cardiomyocytes apoptosis and depression. On the other hand, in
our sepsis model we also found the expression of Bcl-2 of cardiac
tissues were increased by Thaliporphine, which could counteract
LPS induced apoptosis (data not shown).
In our previous study, Thaliporphine could ameliorate LPS-
induced cardiac depression through attenuating TLR4 signaling in
cardiomyocytes to prevent SERCA2 from nitrosylation via
decreasing iNOS and TNFa expression [14]. However, change
of SERCA2 nitrosylation was not observed in this study (data not
shown). Endotoxic shock has been shown to impair SERCA2
activity in subcellular fractions in some [43,44] but not all studies
[6,45,46]. This discrepancy may be explained by inter-study
variations such as different cardiac loading, circulating catecho-
lamines, animal models, materials to induce sepsis, or induction
periods. That also means Thaliporphine protects heart from
cardiac depression by decreasing SERCA2 nitrosylation is not the
only mechanism. In other studies, it was also proved that intrinsic
myocardial depression is largely related to LPS-mediated sarco-
lemmal alterations, which shorten action potential duration, and is
not due to alterations in SR function [6].
Serum levels of cardiac enzymes such as CKMB and LDH are
essential to the diagnosis of myocardial damage. A new serum
marker, cardiac troponin I (cTnI), has been developed for the
detection of cardiac injury and diagnosis of septic myocarditis
[47]. It is specific for cardiac tissue and is detected in the serum
only if myocardial has been injured. It is considered to be more
sensitive and specific than CKMB and LDH [48]. Polymorpho-
nuclear neutrophil (PMN) infiltration in the myocardial inter-
stitum is also an important event to myocardial dysfunction in
sepsis [49,50]. PMN is the most abundant white blood cells and is
an important part of the innate immune system. Animal Studies
indicate PMN activation can directly injure cardiomyocytes [51].
In this study, Thaliporphine could reverse the LPS-induced
dramatic increases of both cTnI and LDH without significant
changes of PMN and LYM. Thus the decreases in myocardial
injury markers were not related to changes in circulating PMN.
The LPS induced increases in these markers were accompanied by
decreases in myocardial contractility as we mentioned above.
The mechanisms involved in myocardial dysfunction in sepsis
is multifactorial, inflammatory cytokines, NO, and other factors
all play important roles [7,8,9]. According to our previous data
in endotoxemic rat, the serum level of nitrate was increased up to
10 folds than sham group after 4 hours injection of LPS [13].
However, the administration of L-arginine analogues in vivo,
competing with natural L-arginine for nitric oxide synthase
(NOS), does not ameliorate cardiac depression, suggesting that
NO may not play a significant role in heart dysfunction in vivo
[52]. Intracellular acidosis has negative inotropic effects by
impairing excitation-contraction coupling and decreasing myofil-
ament sensitivity to Ca
2+ [53]. Although serum acidosis may
produce intracellular acidosis in hearts, the intact heart appears
more resistant to acidosis [54]. The serum acidosis may be
rapidly corrected by adjusting the respiratory rate or other
compensation mechanisms in vivo. Therefore, it is unlikely that
transient serum acidosis contributed to the sustained cardiac
depression. In the present study, we found serum pH was slightly
decreased in LPS treated rabbits, but not to the acidosis degree
and this decrease was reversed with Thaliporphine administra-
Figure 6. Cytokine protein array analysis of serum from sham,
LPS, LPS plus 3 mg/kg Thaliporphine (LPS/T3), and Thalipor-
phine alone (T3) groups. Red circles indicate differences observed
between sham and LPS. CINC-1, TIMP-1, and VEGF were markedly
increased in LPS group but not both LPS/T3 and T3 group. The six signal
points in the membrane of sham group indicate experimental positive
controls.
doi:10.1371/journal.pone.0039174.g006
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protect sepsis-associated myocardial dysfunction in both preload-
dependent and independent ways. This protective effect is related
to the increase of ‘‘good’’ – PI3K/Akt/mTOR and decrease of
‘‘bad’’ – p38/NFkB pathways, which is associated with
diminishing TNFa and caspase 3 dependent apoptosis.
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